ClinicalTrials.gg
RecruitingNCT07614399PSEUDOUpdated May 29, 2026

Conservative vs Interventional Management of Postsurgical CSF Pseudomeningocele

An interventional study of Lumbar Drainage and Pseudomeningocele Puncture in CSF Leak, CSF Pressure Increased and CSF Circulation Disorder, sponsored by Charles University, Czech Republic. Recruiting at 1 site in Czechia. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-29.

Sponsored by Charles University, Czech Republic · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Nov 2025, registered May 2026).
  • Started Nov 2025; still recruiting 1 year later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Dear Sir or Madam,

You have been invited to participate in a clinical study whose aim is to compare the effectiveness of two different approaches to the treatment of cerebrospinal fluid (CSF) pseudomeningocele - conservative management and interventional treatment (surgical or drainage procedures). CSF pseudomeningocele is a complication that may occur after brain surgery and is characterized by an accumulation of cerebrospinal fluid beneath the skin. At present, there is no clear consensus regarding the optimal treatment approach.

How the study will be conducted

After enrollment in the study, you will be randomly assigned (by chance) to one of two groups:

Conservative management: no surgical intervention, regular follow-up, and wound care.

Interventional treatment: simple aspiration/puncture, insertion of a lumbar drain, or reoperation.

During the study, you will be followed for a period of 1 year. Follow-up examinations will include clinical assessment and brain imaging (CT or MRI) at 4 months and 12 months after enrollment.

Risks associated with the interventional group Simple cyst aspiration/puncture: infection, bleeding into the pseudomeningocele.

Lumbar drainage: infection, meningitis, bleeding at the insertion site, cerebrospinal fluid leakage, nerve root irritation, headaches.

Reoperation: bleeding, infection, complications related to general anesthesia. Expected duration of participation in the study

12 months

Expected total number of participants enrolled in the study

20 participants

Benefit of the study

The aim of the study is to compare the effect of surgical intervention with conservative management.

Compensation for participation

Participation in this study is not associated with any financial compensation.

02

Conditions studied

  • CSF Leak
  • CSF Pressure Increased
  • CSF Circulation Disorder
  • Puncture

Keywords

  • Cerebrospinal Fluid Leak
  • Postoperative Complications
  • Neurosurgery
03

In context

Intracranial Hypertension

166 studies on the registry are indexed under Intracranial Hypertension; 37 are open to participants now.

This study's planned enrollment of 60 is above the median of 50 across 81 interventional studies indexed under Intracranial Hypertension.

Browse Intracranial Hypertension studies →

Lead sponsor

Charles University, Czech Republic is the lead sponsor of 228 studies on the registry; 76 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pseudomeningocele after elective intracranial surgery
  • Willing and able to give
  • No prior cranial or spinal surgical intervention
  • Pseudomeningocele Palpation Scale (PPS) II-IV, no severe pain of the PMC (VAS 7-10) - Tension MK

Exclusion criteria

Exclusion Criteria:

  • PMC following emergency or trauma surgery
  • Known or suspected infection at the PMC site at recruitment
  • Severe comorbidities preventing participation (e.g. terminal illness, organ failure)
  • Conditions requiring urgent unrelated surgical intervention
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • No intervention
    Conservative

    Patients managed without surgical procedures, except for skin sutures.

  • Experimental
    Interventional

    Patients undergoing local treatment - lumbar drainage insertion, simple wound puncture, fibrin glue or any combination.

    Procedure: Lumbar Drainage · Procedure: Pseudomeningocele Puncture · Procedure: Puncture with Fibrin Glue Application · Procedure: Revision

Interventions

  • ProcedureLumbar Drainage

    Insertion of Lumbar drain

  • ProcedurePseudomeningocele Puncture

    aspiration of the CSF fluid with injection

  • ProcedurePuncture with Fibrin Glue Application

    after aspiration of the CSF a fibrin glue is injected into the pseudomeningocele

  • ProcedureRevision

    Revision surgery in order to prevent future pseudomeninogocele formation

06

What researchers measure

Primary outcomes

  1. CSF Leakage or Tension pseudomeningocoele

    New-onset wound CSF leakage requiring revision surgery, or pseudomeningocele associated with severe headaches not responsive to analgesics.

    Time frame: 12 months

Secondary outcomes

  1. Infection

    To compare the infection rate between the two treatment groups.

    Time frame: 12 months

  2. Glasgow Outcome Scale Extended (GOSE)

    To assess functional recovery using the Glasgow Outcome Scale-Extended (GOSE) at 1 year post-surgery.

    Time frame: 12 months

  3. Absorption of the Pseudomeningocoele

    Absorption of pseudomendingocoele at 4 months and 1 year post-surgery assessed by CT or MRI

    Time frame: 12 months

  4. Pain

    Persistence of headache after the surgery - Pain Scale 0-10 (VAS)

    Time frame: 12 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2025 (actual). Primary completion is estimated for Nov 2029, 48 months after the start.

Of 37 non-industry interventional studies with no phase under Intracranial Hypertension, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 39. This study's planned 48 months is above that.

Counting every sponsor, half of 38 studies reached it within 18 months; a quarter within 6 and three quarters within 39.

How these figures are worked out, and which studies are left out of them.

Registered
May 15, 2026
First posted
May 29, 2026
StartActual
Nov 1, 2025
Primary completionEst.
Nov 1, 2029
CompletionEst.
Nov 1, 2030
Last update
May 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 29, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07614399
Responsible party
Norbert Svoboda (Neurosurgeon, Consultant, Head of Department of Cranial Surgery., Charles University, Czech Republic) — Principal investigator
First posted
May 29, 2026
Start date
Nov 1, 2025
Primary completion
Nov 1, 2029 (estimated)
Completion
Nov 1, 2030 (estimated)
Last update
May 29, 2026

Study contacts

Norbert Svoboda, MD, PhD, FEBNS
Contact
norbert.svoboda@uvn.cz
++420973202932

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion